Related Experiment Video
Updated: Apr 13, 2026
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
Published on: March 9, 2019
Corneal penetration of gold nanoparticles--therapeutic implications
Abstract:
Gold nanoparticles can show anti-glycation activity thereby preventing the aggregation of proteins. As glycation is one of the leading causes of cataract formation, the finding is important in therapeutic management of ocular pathology that follows cataract formation (e.g., cortical changes often resulting in nuclear sclerosis). In the present study, we have successfully conducted in vivo experiments using guinea pig models. While the anti-glycation property of GNPs is known in vitro, the present work for the first time shows corneal penetration of GNPs. The therapeutic promise of using GNP as an anti-cataract agent thus seems imminent. GNPs traverse and get deposited into different layers of the cornea as examined by Transmission Electron Microscopy (TEM).
Insights
Gold nanoparticles (GNPs) demonstrate anti-glycation properties, preventing protein aggregation. This study confirms their in vivo corneal penetration, showing therapeutic promise for preventing cataract formation and related ocular pathologies.
Area of Science:
- Ocular pathology
- Nanomedicine
- Biochemistry
Background:
- Glycation, a process leading to protein aggregation, is a primary cause of cataract formation.
- Gold nanoparticles (GNPs) have demonstrated anti-glycation activity in vitro.
- Cataract formation can lead to secondary ocular pathologies like nuclear sclerosis.
Purpose of the Study:
- To investigate the in vivo efficacy of gold nanoparticles (GNPs) as an anti-cataract agent.
- To determine if GNPs can penetrate the cornea in a living model.
- To assess the potential of GNPs in managing glycation-induced ocular conditions.
Main Methods:
- In vivo experiments were conducted using guinea pig models.
- Corneal penetration of GNPs was assessed.
- Transmission Electron Microscopy (TEM) was used to examine GNP deposition in corneal layers.
Main Results:
- Gold nanoparticles (GNPs) exhibited anti-glycation activity.
- The study confirmed corneal penetration of GNPs in vivo for the first time.
- TEM analysis showed GNPs deposited in various layers of the cornea.
Conclusions:
- Gold nanoparticles (GNPs) show significant therapeutic potential as an anti-cataract agent.
- The demonstrated corneal penetration supports the use of GNPs for ocular applications.
- Further research into GNP-based therapies for glycation-related eye diseases is warranted.
